Custom GMP Cell Line Development Service
High Producer Cell Line & GMP-compliant Technology Platforms
Benefit from trenzyme´s long-standing expertise in GMP-compliant cell line development. Our fully controlled, regulatory-compliant processes, which include LIMS-based documentation and a full audit trail, enable the generation of GMP-compliant cell lines that can be used from the research and development phase through to the successful launch of high-quality therapeutic antibodies and proteins onto the healthcare market.
The development of highly productive production cell lines and efficient assay cell lines represents a significant challenge for any pharmaceutical developer or service provider, particularly when subsequent Good Manufacturing Practice (GMP) compliance is required in order to fulfil all relevant pharmaceutical guideline specifications. As a reliable partner for the biotechnology and pharmaceutical industry, with many years of experience in cell line development, we provide industry-leading CHO-based, GMP-compliant technology platforms for the generation of high-performance, clonal production cell lines.
To optimally meet your specific project requirements, we always work in close collaboration with our clients to ensure transparency, high quality and maximum success.
Process of GMP compliant Cell Line Development Service
Under Regulatory compliant Conditions
Further Options
GMP Cell Line Development Service
Highly flexible and tailor-made solutions for your application. If you require an option that is not listed, please contact us – we will find the ideal solution for you:
Benefits & Features of our
cGMP-compliant Technology Process
Your Way from R&D to Market
Process from GMP Cell Line Development to Your Final Product
What Our Clients Say About Us
GMP-compliant Cell Line Development Service FAQs
Which parental cell lines do you use?
We use Celonic’s CHOvolution® CHO-K1 and Thermofisher’s Freedom ExpiCHO-S™ as parental cell lines. Other cell lines on request.
What is the final productivity of the cell line after cell line development?
As a high standard productivity, we can reach up to 3 g/l for mABs after cell line development. After process development, it can reach > 8 g/l.
Which type of license do you offer?
Within the cell line generation at trenzyme, a R&D license is already included and has not to be purchased. For any commercial application later on, a commercial license is needed.